4
Changes in Ownership
Foghorn Therapeutics Inc. Filed Acc 0001562180-22-000747
Options or other derivatives
- Chief Executive Officer acquired 440,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| GOTTSCHALK ADRIAN Chief Executive Officer | 2022-01-26 | Grant or award · Stock Option (right to buy) | +440,000 | 440,000 | D | ||
Loading xslF345X03/primarydocument.xml…